A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)
Crohn's Disease
What this study involves
The registry says this study is recruiting. Individual locations may have different availability.
- Study type
- Interventional
- Phase
- Phase 3
- Age range
- 16 years - 80 years
- Sex eligible
- All sexes
- Healthy volunteers
- Not accepted
- Participants
- 1200 Estimated
These are starting points, not an eligibility decision. The research team must review the full requirements.
About the research
The purpose of this protocol is to evaluate the efficacy and safety of tulisokibart in participants with moderately to severely active Crohn's disease. Study 1's primary hypotheses are that at least 1 tulisokibart dose level is superior to placebo in the proportion of participants achieving clinical remission per Crohn's Disease Activity Index score (\<150, US/FDA) or per stool frequency and abdominal pain score (EU/EMA) and in the proportion of participants achieving endoscopic response at Week 52 (US/FDA and EU/EMA), and that at least 1 tulisokibart dose level is superior to placebo in the proportion of participants achieving clinical remission per Crohn's Disease Activity Index score (\<150, US/FDA) or per stool frequency and abdominal pain score (EU/EMA) and in the proportion of participants achieving endoscopic response at Week 12 (US/FDA and EU/EMA). Study 2's primary hypothesis is that at least 1 tulisokibart dose level is superior to placebo in the proportion of participants achieving clinical remission per Crohn's Disease Activity Index score (\<150, US/FDA) or stool frequency and abdominal pain score (EU/EMA) and in the proportion of participants achieving endoscopic response at Week 12 (US/FDA and EU/EMA).
Read the full description
The protocol consists of 2 studies. Study 1 includes induction and maintenance treatment, and Study 2 includes only induction treatment. Each study has its own hypotheses and outcome measures that will be assessed independently.
Who may be able to participate?
The list below is the sponsor’s full registry wording. It can include conditions, prior treatment, test results and other requirements. A match in search does not mean you qualify.
The main inclusion and exclusion criteria include but are not limited to the following:
Inclusion Criteria:
- Has had a diagnosis of Crohn's disease (CD) at least 3 months before study.
- Has moderately to severely active CD.
- Demonstrated inadequate response, loss of response, or intolerance to one or more of the following categories of drugs: oral locally acting steroids, systemic steroids, immunomodulators, biologic and/or small molecule advanced therapies.
- Adolescent participants ≥16 and \<18 years of age can participate if approved by the country or regulatory/health authority.
Exclusion Criteria:
- Has diagnosis of ulcerative colitis (UC) or indeterminate colitis.
- Has CD isolated to the stomach, duodenum, jejunum, or perianal region, without colonic and/or ileal involvement.
- Currently has any of the following complications of CD: suspected or diagnosed with intra-abdominal or perianal abscess, known symptomatic stricture or colonic stenosis not passable in endoscopy, fulminant colitis, toxic megacolon, or any other manifestation that might require surgery while enrolled in the study.
- Has current stoma or need for colostomy or ileostomy.
- Is missing \>2 segments of the following 5 segments: terminal ileum, right colon, transverse colon, sigmoid and left colon, and rectum.
- Has been diagnosed with short gut or short bowel syndrome, or any other uncontrolled chronic diarrhea besides CD.
- Has surgical bowel resection within 3 months of study.
- Has prior or current gastrointestinal dysplasia.
- Has chronic infection requiring ongoing antimicrobial treatment.
- Has a history of cancer (except fully treated non-melanoma skin cell cancers or cervical carcinoma in situ after complete surgical removal) and is disease free for \<5 years.
- Is infected with Hepatitis B virus (HBV), Hepatitis C virus (HCV), or human immunodeficiency virus (HIV).
- Has active tuberculosis.
- Has confirmed or suspected coronavirus disease of 2019 (COVID-19) infection.
- Prior exposure to tulisokibart (MK-7240, PRA023) or another anti-tumor necrosis factor-like cytokine 1A (TL1A) antibody (Ab).
Treatment, groups and participation
The registry may describe treatments and study duration without a complete visit calendar. Ask the study team for the exact schedule, procedures, risks, costs and alternatives. Keep your usual care plan unless your treating clinician tells you otherwise.
- Assignment
- Random assignment
- Masking
- Quadruple masked
Study 1: High Dose Induction, High Dose Maintenance
Participants receive high dose intravenous (IV) tulisokibart, followed by a high dose subcutaneous (SC) tulisokibart regimen.
Drug: IV Tulisokibart · Drug: SC Tulisokibart
Study 1: High Dose Induction, Low Dose Maintenance
Participants receive high dose IV tulisokibart, followed by a low dose SC tulisokibart regimen.
Drug: IV Tulisokibart · Drug: SC Tulisokibart · Other: SC Placebo
Study 1: Low Dose Induction, Low Dose Maintenance
Participants receive low dose IV tulisokibart, followed by a low dose SC tulisokibart regimen.
Drug: IV Tulisokibart · Drug: SC Tulisokibart · Other: SC Placebo
Study 1: Placebo
Participants receive IV placebo, followed by an SC placebo regimen.
Drug: IV Tulisokibart · Other: IV Placebo · Other: SC Placebo
Study 1: High Dose Extension
Participants receive a high dose SC tulisokibart regimen. Participants may continue in this arm after completing participation in their original arm, if they meet protocol-specific prerequisites.
Drug: SC Tulisokibart
Study 1: Low Dose Extension
Participants receive a low dose SC tulisokibart and placebo regimen. Participants may continue in this arm after completing participation in their original arm, if they meet protocol-specific prerequisites.
Drug: SC Tulisokibart · Other: SC Placebo
Study 2: High Dose Induction
Participants receive high dose IV tulisokibart.
Drug: IV Tulisokibart
Study 2: Low Dose Induction
Participants receive low dose IV tulisokibart.
Drug: IV Tulisokibart · Other: SC Placebo
Study 2: Placebo
Participants receive IV placebo.
Drug: IV Tulisokibart · Other: IV Placebo · Other: SC Placebo
Study 2: High Dose Extension
Participants receive a high dose SC tulisokibart regimen. Participants may continue in this arm only after completing participation in their original arm, if they meet protocol-specific prerequisites.
Drug: SC Tulisokibart
Study 2: Low Dose Extension
Participants receive a low dose SC tulisokibart regimen. Participants may continue in this arm only after completing participation in their original arm, if they meet protocol-specific prerequisites.
Drug: SC Tulisokibart
IV Tulisokibart DRUG
Humanized monoclonal antibody that binds human tumor necrosis factor-like cytokine 1A (TL1A), administered intravenously
SC Tulisokibart DRUG
Humanized monoclonal antibody that binds human TL1A, administered subcutaneously
IV Placebo OTHER
Placebo matching IV tulisokibart
SC Placebo OTHER
Placebo matching SC tulisokibart
What researchers are measuring
Outcome measures describe what is being studied. They are not proof that a treatment works.
Primary measures
Study 1 [US/FDA Only]: Percentage of Participants Achieving Clinical Remission per Crohn's Disease Activity Index (CDAI) Score at Week 52
Time frame: Week 52
The percentage of participants achieving clinical remission, as defined by CDAI score \<150 for Study 1 will be presented.
Study 1 [EU/EMA Only]: Percentage of Participants Achieving Clinical Remission per Stool Frequency and Abdominal Pain Score at Week 52
Time frame: Week 52
The percentage of participants achieving clinical remission per stool frequency/abdominal pain score (SF/APS), as defined by average daily SF ≤2.8 and average daily APS ≤1.0 and both not greater than baseline for Study 1 will be presented.
Study 1: Percentage of Participants Achieving Endoscopic Response at Week 52
Time frame: Week 52
The percentage of participants achieving endoscopic response, as defined by a ≥50% decrease in Simplified endoscopic score for Crohn's disease (SES-CD) from baseline for Study 1 will be presented.
Study 1 [US/FDA Only]: Percentage of Participants Achieving Clinical Remission per CDAI Score at Week 12
Time frame: Week 12
The percentage of participants achieving clinical remission, as defined by CDAI score \<150 for Study 1 will be presented.
Study 1 [EU/EMA Only]: Percentage of Participants Achieving Clinical Remission per Stool Frequency and Abdominal Pain Score at Week 12
Time frame: Week 12
The percentage of participants achieving clinical remission per SF/APS, as defined by average daily SF ≤2.8 and average daily APS ≤1.0 and both not greater than baseline for Study 1 will be presented.
Study 1: Percentage of Participants Achieving Endoscopic Response at Week 12
Time frame: Week 12
The percentage of participants achieving endoscopic response, as defined by a ≥50% decrease in SES-CD from baseline for Study 1 will be presented.
Study 2 [US/FDA Only]: Percentage of Participants Achieving Clinical Remission per CDAI Score at Week 12
Time frame: Week 12
The percentage of participants achieving clinical remission, as defined by CDAI score \<150 for Study 2 will be presented.
Study 2 [EU/EMA Only]: Percentage of Participants Achieving Clinical Remission per Stool Frequency and Abdominal Pain Score at Week 12
Time frame: Week 12
The percentage of participants achieving clinical remission per SF/APS, as defined by average daily SF ≤2.8 and average daily APS ≤1.0 and both not greater than baseline for Study 2 will be presented.
Study 2: Percentage of Participants Achieving Endoscopic Response at Week 12
Time frame: Week 12
The percentage of participants achieving endoscopic response, as defined by a ≥50% decrease in SES-CD from baseline for Study 2 will be presented.
Secondary measures
Study 1: Number of Participants Who Experienced an Adverse Event (AE)
Time frame: Up to approximately 52 weeks
An AE is any untoward medical occurrence in a clinical study participant, temporally associated with the use of study intervention, whether or not considered related to the study intervention. An AE can therefore be any unfavorable and unintended sign (including an abnormal laboratory finding), symptom, or disease (new or exacerbated) temporally associated with the use of a study intervention. The number of participants who experience an AE for Study 1 will be presented.
Study 1: Number of Participants Who Discontinue Study Intervention due to an AE
Time frame: Up to approximately 52 weeks
An AE is any untoward medical occurrence in a clinical study participant, temporally associated with the use of study intervention, whether or not considered related to the study intervention. An AE can therefore be any unfavorable and unintended sign (including an abnormal laboratory finding), symptom, or disease (new or exacerbated) temporally associated with the use of a study intervention. The number of participants who discontinue study intervention due to an AE for Study 1 will be presented.
Study 1 [US/FDA Only]: Percentage of Participants Achieving Clinical Remission per Stool Frequency and Abdominal Pain Score at Week 12
Time frame: Week 12
The percentage of participants achieving clinical remission per SF/APS, as defined by average daily SF ≤2.8 and average daily APS ≤1.0 and both not greater than baseline for Study 1 will be presented.
Study 1 [EU/EMA Only]: Percentage of Participants Achieving Clinical Remission per CDAI Score at Week 12
Time frame: Week 12
The percentage of participants achieving clinical remission, as defined by CDAI score \<150 for Study 1 will be presented.
Study 1: Percentage of Participants With Clinical Response per CDAI Score (Decrease From Baseline of ≥100 Points) at Week 12
Time frame: Week 12
The percentage of participants achieving clinical response, defined as decrease from baseline of ≥100 points in CDAI for Study 1 will be presented.
Study 1: Mean Change From Baseline in Functional Assessment of Chronic Illness Therapy - Fatigue (FACIT-Fatigue) Score at Week 12
Time frame: Baseline and Week 12
The FACIT-Fatigue is a 13-item measure that assesses self-reported fatigue and its impact upon daily activities and function, scored on a 0 to 52-point scale, with lower scores indicating greater fatigue. The mean change from baseline in FACIT-Fatigue score for Study 1 will be presented.
Study 1: Percentage of Participants Achieving Endoscopic Remission at Week 12
Time frame: Week 12
The percentage of participants achieving endoscopic remission, as defined by SES-CD ≤4 and at least 2-point reduction from baseline and no subscore \>1 in any individual variable for Study 1 will be presented. SES-CD evaluates 4 endoscopic variables (ulcer size, ulcerated surface, affected surface, and narrowing), each on a scale from 0 to 3, in 5 segments assessed during ileocolonoscopy (ileum, right colon, transverse colon, left colon/sigmoid, and rectum). The total score is the sum of the 4 endoscopic variable scores and ranges from 0 to 56, where higher scores indicate more severe disease.
Study 1 and 2: Percentage of Participants in Diagnostic Assay Positive (Dx+) Subpopulation Achieving Clinical Remission per CDAI Score at Week 12
Time frame: Week 12
Dx+ participants are those who meet protocol-specific diagnostic assay criteria during screening. The percentage of Dx+ participants achieving clinical remission, as defined by CDAI score \<150 for Study 1 and Study 2 will be presented.
Study 1 and 2: Percentage of Participants in Dx+ Subpopulation Achieving Endoscopic Response at Week 12
Time frame: Week 12
Dx+ participants are those who meet protocol-specific diagnostic assay criteria during screening. The percentage of Dx+ participants achieving endoscopic response, as defined by a ≥50% decrease in simplified endoscopic score for Crohn's disease (CD) from baseline for Study 1 and Study 2 will be presented.
Study 1: Percentage of Participants With Clinical Response (Decrease From Baseline at Least 100 Points) or Clinical Remission (<150) per CDAI Score at Week 6
Time frame: Week 6
The percentage of participants achieving clinical response (defined as decrease from baseline of ≥100 points in CDAI) or clinical remission (defined as CDAI \<150) for Study 1 will be presented.
Study 1 [US/FDA Only]: Percentage of Participants Achieving Clinical Remission per Stool Frequency and Abdominal Pain Score at Week 52
Time frame: Week 52
The percentage of participants achieving clinical remission per SF/APS, as defined by average daily SF ≤2.8 and average daily APS ≤1.0 and both not greater than baseline for Study 1 will be presented.
Study 1 [EU/EMA Only]: Percentage of Participants Achieving Clinical Remission per CDAI Score at Week 52
Time frame: Week 52
The percentage of participants achieving clinical remission, as defined by CDAI score \<150 for Study 1 will be presented.
Study 1: Percentage of Participants With Clinical Response per CDAI Score (Decreased From Baseline of ≥100 Points) at Week 52
Time frame: Week 52
The percentage of participants achieving clinical response, defined as decrease from baseline of ≥100 points in CDAI for Study 1 will be presented.
Study 1: Percentage of Participants Achieving Endoscopic Remission at Week 52
Time frame: Week 52
The percentage of participants achieving endoscopic remission, as defined by SES-CD ≤4 and at least 2-point reduction from baseline and no subscore \>1 in any individual variable for Study 1 will be presented. SES-CD evaluates 4 endoscopic variables (ulcer size, ulcerated surface, affected surface, and narrowing), each on a scale from 0 to 3, in 5 segments assessed during ileocolonoscopy (ileum, right colon, transverse colon, left colon/sigmoid, and rectum). The total score is the sum of the 4 endoscopic variable scores and ranges from 0 to 56, where higher scores indicate more severe disease.
Study 1: Percentage of Participants Achieving Sustained Clinical Remission per CDAI at Both Week 12 and Week 52
Time frame: Week 12 and Week 52
The percentage of participants achieving sustained clinical remission, as defined by CDAI score \<150 for Study 1 will be presented.
Study 1 [US/FDA Only]: Percentage of Participants Achieving Corticosteroid-Free Clinical Remission per CDAI Score at Week 52
Time frame: Week 52
The percentage of participants who are in clinical remission as defined by CDAI score \<150 and without corticosteroid use for CD at least 90 days prior to that assessment for Study 1 will be presented.
Study 1 [EU/EMA Only]: Percentage of Participants Achieving Corticosteroid-Free Clinical Remission per Stool Frequency and Abdominal Pain Score at Week 52
Time frame: Week 52
The percentage of participants who are in clinical remission per SF/APS, as defined by average daily SF ≤2.8 and average daily APS ≤1.0 and both not greater than baseline and without corticosteroid use for CD at least 90 days prior to that assessment for Study 1 will be presented.
Study 1: Percentage of Participants Achieving Clinical Remission per Stool Frequency, Abdominal Pain Score, and Endoscopic Remission at Week 52
Time frame: Week 52
The percentage of participants achieving clinical remission per SF/APS, as defined by average daily SF ≤2.8 and average daily APS ≤1.0 and both not greater than baseline, and achieving endoscopic remission, as defined by SES-CD ≤4 and at least 2-point reduction from baseline and no subscore \>1 in any individual variable for Study 1 will be presented.
Study 1: Percentage of Participants Achieving Clinical Remission per CDAI Score and Endoscopic Remission at Week 52
Time frame: Week 52
The percentage of participants achieving clinical remission as defined by CDAI score \<150, and achieving endoscopic remission, as defined by SES-CD ≤4 and at least 2-point reduction from baseline and no subscore \>1 in any individual variable for Study 1 will be presented.
Study 1: Mean Change From Baseline in FACIT-Fatigue Score at Week 52
Time frame: Baseline and Week 52
The FACIT-Fatigue is a 13-item measure that assesses self-reported fatigue and its impact upon daily activities and function, scored on a 0 to 52-point scale, with lower scores indicating greater. The mean change from baseline in FACIT-Fatigue score for Study 1 will be presented.
Study 1 [EU/EMA Only]: Mean Change From Baseline in Inflammatory Bowel Disease Questionnaire (IBDQ) Score at Week 52
Time frame: Baseline and Week 52
The IBDQ measures health related quality of life in participants with inflammatory bowel disease. It consists of 32 questions each with a graded response of 1 (worst) to 7 (best). The score ranges between 32 to 224, with higher scores indicating a better quality of life. The mean change from baseline in IBDQ score for Study 1 will be presented.
Study 1: Percentage of Participants With Ulcer-Free Endoscopy at Week 52
Time frame: Week 52
The percentage of participants achieving ulcer-free endoscopy (mucosal healing), as defined by SES-CD ulcerated surface subscore of 0 in participants with SES-CD ulcerated surface subscore ≥1 at baseline for Study 1 will be presented.
Study 2: Number of Participants Who Experienced an AE
Time frame: Up to approximately 12 weeks
An AE is any untoward medical occurrence in a clinical study participant, temporally associated with the use of study intervention, whether or not considered related to the study intervention. An AE can therefore be any unfavorable and unintended sign (including an abnormal laboratory finding), symptom, or disease (new or exacerbated) temporally associated with the use of a study intervention. The number of participants who experience an AE for Study 2 will be presented.
Study 2: Number of Participants Who Discontinue Study Intervention due to an AE
Time frame: Up to approximately 12 weeks
An AE is any untoward medical occurrence in a clinical study participant, temporally associated with the use of study intervention, whether or not considered related to the study intervention. An AE can therefore be any unfavorable and unintended sign (including an abnormal laboratory finding), symptom, or disease (new or exacerbated) temporally associated with the use of a study intervention. The number of participants who discontinue study intervention due to an AE for Study 2 will be presented.
Study 2 [US/FDA Only]: Percentage of Participants Achieving Clinical Remission per Stool Frequency and Abdominal Pain Score at Week 12
Time frame: Week 12
The percentage of participants achieving clinical remission per SF/APS, as defined by average daily SF ≤2.8 and average daily APS ≤1.0 and both not greater than baseline for Study 2 will be presented.
Study 2 [EU/EMA Only]: Percentage of Participants Achieving Clinical Remission per CDAI Score at Week 12
Time frame: Week 12
The percentage of participants achieving clinical remission, as defined by CDAI score \<150 for Study 2 will be presented.
Study 2: Percentage of Participants With Clinical Response per CDAI Score (Decreased From Baseline of ≥100 Points) at Week 12
Time frame: Week 12
The percentage of participants achieving clinical response, defined as decrease from baseline of ≥100 points in CDAI for Study 2 will be presented.
Study 2: Mean Change From Baseline in FACIT-Fatigue Score at Week 12
Time frame: Baseline and Week 12
The FACIT-Fatigue is a 13-item measure that assesses self-reported fatigue and its impact upon daily activities and function, scored on a 0 to 52-point scale, with lower scores indicating greater. The mean change from baseline in FACIT-Fatigue score for Study 2 will be presented.
Study 2: Percentage of Participants Achieving Endoscopic Remission at Week 12
Time frame: Week 12
The percentage of participants achieving endoscopic remission, as defined by SES-CD ≤4 and at least 2-point reduction from baseline and no subscore \>1 in any individual variable for Study 2 will be presented. SES-CD evaluates 4 endoscopic variables (ulcer size, ulcerated surface, affected surface, and narrowing), each on a scale from 0 to 3, in 5 segments assessed during ileocolonoscopy (ileum, right colon, transverse colon, left colon/sigmoid, and rectum). The total score is the sum of the 4 endoscopic variable scores and ranges from 0 to 56, where higher scores indicate more severe disease.
Study 2 [EU/EMA Only]: Mean Change From Baseline in IBDQ Score at Week 12
Time frame: Baseline and Week 12
The IBDQ measures health related quality of life in participants with inflammatory bowel disease. It consists of 32 questions each with a graded response of 1 (worst) to 7 (best). The score ranges between 32 to 224, with higher scores indicating a better quality of life. The mean change from baseline in IBDQ score for Study 2 will be presented.
Study 2: Percentage of Participants With Clinical Response (Decreased From Baseline of ≥100 Points) or Clinical Remission (<150) per CDAI Score at Week 6
Time frame: Week 6
The percentage of participants achieving clinical response (defined as decrease from baseline of ≥100 points in CDAI) or clinical remission (defined as CDAI \<150) for Study 2 will be presented.
Study 2: Percentage of Participants With Ulcer-Free Endoscopy at Week 12
Time frame: Week 12
The percentage of participants achieving ulcer-free endoscopy (mucosal healing), as defined by SES-CD ulcerated surface subscore of 0 in participants with SES-CD ulcerated surface subscore ≥1 at baseline for Study 2 will be presented.
Review the complete result tables and limitations in the official record.
Open official results ↗Research locations (499)
The overall study status and a local site’s status can differ. Confirm that location’s availability before traveling.
499 locations
Digestive Health Specialists ( Site 5064)Dothan, Alabama, United StatesCompleted
Arizona Arthritis & Rheumatology Research, PC ( Site 5094)Phoenix, Arizona, United StatesCompleted
GI Alliance - Sun City ( Site 5118)Sun City, Arizona, United StatesRecruiting
University of Arizona Clinical and Translational Sciences Research Center ( Site 5111)Tucson, Arizona, United StatesRecruiting
University of Arkansas for Medical Sciences ( Site 5147)Little Rock, Arkansas, United StatesRecruiting
Clinnova Research ( Site 5110)Anaheim, California, United StatesRecruiting
Southern California Research Center ( Site 5044)Coronado, California, United StatesRecruiting
Om Research LLC ( Site 5038)Lancaster, California, United StatesRecruiting
Cedars Sinai Medical Center ( Site 5080)Los Angeles, California, United StatesRecruiting
UCLA Clinical & Translational Research Center (CTRC) ( Site 5116)Los Angeles, California, United StatesRecruiting
University of California, Irvine (UCI) Health - UC Irvine Medical Center ( Site 5128)Orange, California, United StatesRecruiting
Om Research LLC ( Site 5045)Oxnard, California, United StatesRecruiting
Clinical Applications Laboratories ( Site 5123)San Diego, California, United StatesRecruiting
Amicis Research Center ( Site 5055)Valencia, California, United StatesCompleted
University of Colorado Anschutz Medical Campus-Division of Gastroenterology and Hepatology ( Site 5026)Aurora, Colorado, United StatesRecruiting
Peak Gastroenterology Associates ( Site 5023)Colorado Springs, Colorado, United StatesRecruiting
South Denver Gastroenterology, PC ( Site 5132)Englewood, Colorado, United StatesRecruiting
Rocky Mountain Gastroenterology ( Site 5082)Lakewood, Colorado, United StatesRecruiting
Medical Research Center of Connecticut ( Site 5005)Hamden, Connecticut, United StatesCompleted
Yale University School of Medicine-Digestive Disease ( Site 5019)New Haven, Connecticut, United StatesRecruiting
Emerson Clinical Research Institute ( Site 5051)Washington D.C., District of Columbia, United StatesRecruiting
Gastroenterology Consultants of Clearwater ( Site 5052)Clearwater, Florida, United StatesActive, not recruiting
Covenant Metabolic Specialists, LLC ( Site 5150)Fort Myers, Florida, United StatesRecruiting
Nature Coast Clinical Research - Inverness ( Site 5042)Inverness, Florida, United StatesRecruiting
Atlantic Medical Research ( Site 5073)Margate, Florida, United StatesActive, not recruiting
Sanchez Clinical Research ( Site 5144)Miami, Florida, United StatesRecruiting
AdventHealth Orlando ( Site 5131)Orlando, Florida, United StatesRecruiting
Endoscopic Research Inc ( Site 5061)Orlando, Florida, United StatesRecruiting
Orlando Health-Digestive Health Institute ( Site 5010)Orlando, Florida, United StatesCompleted
USF Health Carol and Frank Morsani Center for Advanced Healthcare ( Site 5039)Tampa, Florida, United StatesRecruiting
Covenant Metabolic Specialists, LLC ( Site 5143)University Park, Florida, United StatesRecruiting
Morehouse School Of Medicine ( Site 5071)Atlanta, Georgia, United StatesRecruiting
Atlanta Center for Gastroenterology ( Site 5035)Decatur, Georgia, United StatesCompleted
Gastroenterology Associates of Central Georgia ( Site 5048)Macon, Georgia, United StatesRecruiting
Eagle Clinical Research ( Site 5089)Chicago, Illinois, United StatesCompleted
University of Chicago Medical Center ( Site 5066)Chicago, Illinois, United StatesRecruiting
Endeavor Health ( Site 5018)Evanston, Illinois, United StatesRecruiting
GI ALLIANCE - GURNEE ( Site 5003)Gurnee, Illinois, United StatesRecruiting
Indiana University Health University Hospital ( Site 5022)Indianapolis, Indiana, United StatesRecruiting
Iowa Digestive Disease Center ( Site 5007)Clive, Iowa, United StatesRecruiting
University of Kansas Medical Center ( Site 5091)Kansas City, Kansas, United StatesRecruiting
Cotton O'Neil Digestive Health Center ( Site 5033)Topeka, Kansas, United StatesRecruiting
University of Louisville Hospital ( Site 5120)Louisville, Kentucky, United StatesRecruiting
Southern Clinical Research ( Site 5095)Zachary, Louisiana, United StatesCompleted
Walter Reed National Military Medical Center ( Site 5006)Bethesda, Maryland, United StatesRecruiting
Massachusetts General Hospital-Crohn's and Colitis Center ( Site 5037)Boston, Massachusetts, United StatesRecruiting
University of Michigan ( Site 5060)Ann Arbor, Michigan, United StatesRecruiting
Clinical Research Institute of Michigan, LLC ( Site 5002)Clinton Township, Michigan, United StatesRecruiting
Mayo Clinic in Rochester, Minnesota ( Site 5024)Rochester, Minnesota, United StatesRecruiting
Mid-America GI Clinical Research ( Site 5130)Kansas City, Missouri, United StatesRecruiting
BVL Research - Kansas ( Site 5099)Liberty, Missouri, United StatesRecruiting
Washington University School of Medicine ( Site 5058)St Louis, Missouri, United StatesRecruiting
HMH Justice Marie Garibaldi Medical Plaza ( Site 5072)Hackensack, New Jersey, United StatesRecruiting
Northwell Health Physician Partners Center for Advanced IBD Care ( Site 5017)Great Neck, New York, United StatesRecruiting
Circuit Clinical /Crystal Run Healthcare LLP ( Site 5050)Middletown, New York, United StatesActive, not recruiting
NYU Langone Health - Inflammatory Bowel Disease Center (IBD) ( Site 5078)New York, New York, United StatesRecruiting
Weill Cornell Medical College, New-York Presbyterian Hospital ( Site 5079)New York, New York, United StatesRecruiting
New York Gastroenterology Associates ( Site 5013)New York, New York, United StatesRecruiting
Northwell Mather Hospital ( Site 5138)Port Jefferson, New York, United StatesRecruiting
University of North Carolina Medical Center ( Site 5034)Chapel Hill, North Carolina, United StatesRecruiting
Atrium Health Gastroenterology MMP ( Site 5105)Charlotte, North Carolina, United StatesRecruiting
Javara - Tryon Medical Partners ( Site 5046)Charlotte, North Carolina, United StatesCompleted
Great Lakes Gastroenterology Research, LLC ( Site 5016)Mentor, Ohio, United StatesRecruiting
Digestive Disease Specialists Inc. ( Site 5117)Oklahoma City, Oklahoma, United StatesRecruiting
Penn State University Milton S. Hershey Medical Center ( Site 5102)Hershey, Pennsylvania, United StatesRecruiting
Thomas Jefferson University Hospital ( Site 5133)Philadelphia, Pennsylvania, United StatesRecruiting
Frontier Clinical Research, LLC ( Site 5098)Uniontown, Pennsylvania, United StatesRecruiting
University Gastroenterology - Providence - West River Street ( Site 5057)Providence, Rhode Island, United StatesRecruiting
Sanford USD Medical Center ( Site 5129)Sioux Falls, South Dakota, United StatesRecruiting
Vanderbilt Inflammatory Bowel Disease Clinic ( Site 5049)Nashville, Tennessee, United StatesRecruiting
Quality Medical Research ( Site 5114)Nashville, Tennessee, United StatesRecruiting
Baylor University Medical Center ( Site 5031)Dallas, Texas, United StatesRecruiting
GI Alliance - Dallas - Gaston Avenue ( Site 5054)Dallas, Texas, United StatesCompleted
Epic Medical Research - Mesquite ( Site 5153)Denton, Texas, United StatesRecruiting
Baylor College of Medicine Medical Center ( Site 5020)Houston, Texas, United StatesRecruiting
Michael E. DeBakey VA Medical Center ( Site 5086)Houston, Texas, United StatesRecruiting
GI Alliance - Lubbock ( Site 5012)Lubbock, Texas, United StatesCompleted
Caprock Gastro Research ( Site 5077)Lubbock, Texas, United StatesRecruiting
GI Alliance: Mansfield ( Site 5015)Mansfield, Texas, United StatesActive, not recruiting
Southern Star Research Institute ( Site 5000)San Antonio, Texas, United StatesRecruiting
GI Alliance - Southlake ( Site 5109)Southlake, Texas, United StatesRecruiting
Tyler Research Institute ( Site 5001)Tyler, Texas, United StatesRecruiting
Richmond VA Medical Center ( Site 5021)Richmond, Virginia, United StatesRecruiting
Washington Gastroenterology - Bellevue ( Site 5040)Bellevue, Washington, United StatesActive, not recruiting
Swedish Medical Center ( Site 5112)Seattle, Washington, United StatesCompleted
University of Washington ( Site 5115)Seattle, Washington, United StatesRecruiting
Washington Gastroenterology - Tacoma ( Site 5004)Tacoma, Washington, United StatesRecruiting
Concord Repatriation General Hospital-Gastroenterology and Liver Services ( Site 3202)Concord, New South Wales, AustraliaRecruiting
Royal Brisbane and Women's Hospital ( Site 3200)Brisbane, Queensland, AustraliaRecruiting
Mater Misericordiae Limited ( Site 3209)Brisbane, Queensland, AustraliaRecruiting
Royal Adelaide Hosp - GI Clinical Trials ( Site 3203)Adelaide, South Australia, AustraliaRecruiting
Monash Health-Gastroenterology ( Site 3206)Clayton, Victoria, AustraliaRecruiting
The Alfred Hospital-Gastroenterology ( Site 3201)Melbourne, Victoria, AustraliaRecruiting
Medizinische Universität Wien-Klinik für Innere Medizin III - Abteilung für Gastroenterologie und H ( Site 0202)Vienna, State of Vienna, AustriaRecruiting
Medizinische Universitaet Innsbruck-Innere Medizin 1 ( Site 0200)Innsbruck, Tyrol, AustriaRecruiting
Uniklinikum Salzburg-Innere Medizin I ( Site 0201)Salzburg, AustriaRecruiting
UZ Gent ( Site 0300)Ghent, Oost-Vlaanderen, BelgiumRecruiting
UZ Leuven-Gastroenterology - Inflammatory Bowel Disease ( Site 0301)Leuven, Vlaams-Brabant, BelgiumActive, not recruiting
AZ Delta vzw-Gastroenterology ( Site 0304)Roeselare, West-Vlaanderen, BelgiumRecruiting
Hospital de Clinicas de Porto Alegre ( Site 6310)Porto Alegre, Rio Grande do Sul, BrazilRecruiting
Hospital Ernesto Dornelles ( Site 6312)Porto Alegre, Rio Grande do Sul, BrazilRecruiting
Faculdade de Medicina da UNESP ( Site 6308)Botucatu, São Paulo, BrazilRecruiting
Loema Instituto de Pesquisa Clinica ( Site 6302)Campinas, São Paulo, BrazilRecruiting
CECIP - Centro de Estudos do Interior Paulista ( Site 6316)Jaú, São Paulo, BrazilRecruiting
Hospital das Clínicas da Faculdade de Medicina de Ribeirão Preto da Universidade de São Paulo (USP) ( Site 6311)Ribeirão Preto, São Paulo, BrazilRecruiting
Pesquisare Saude ( Site 6304)Santo André, São Paulo, BrazilRecruiting
Centro de Pesquisa Kaiser - CEPEK ( Site 6306)São José do Rio Preto, São Paulo, BrazilRecruiting
BR Trials - Ensaios Clinicos e Consultoria ( Site 6301)São Paulo, BrazilRecruiting
Heritage Medical Research Clinic ( Site 0004)Calgary, Alberta, CanadaRecruiting
Gastroenterology and internal medicine research institute ( Site 0009)Edmonton, Alberta, CanadaRecruiting
Prairie Institute of Liver and Luminal Advanced Research ( Site 0015)Lethbridge, Alberta, CanadaRecruiting
Fraser Clinical Trials Inc ( Site 0001)New Westminster, British Columbia, CanadaRecruiting
G.I.R.I. GI Research Institute Foundation ( Site 0018)Vancouver, British Columbia, CanadaRecruiting
Private Practice - Dr. Bruce Musgrave ( Site 0014)Kentville, Nova Scotia, CanadaRecruiting
Barrie GI Associates ( Site 0016)Barrie, Ontario, CanadaRecruiting
University Hospital - London Health Sciences Centre ( Site 0002)London, Ontario, CanadaRecruiting
London Health Sciences Centre ( Site 0007)London, Ontario, CanadaRecruiting
West GTA Research Inc. ( Site 0020)Mississauga, Ontario, CanadaRecruiting
ABP Research Services Corp. ( Site 0019)Oakville, Ontario, CanadaRecruiting
Toronto Immune & Digestive Health Institute ( Site 0005)Toronto, Ontario, CanadaRecruiting
TDDA Inc. ( Site 0006)Vaughan, Ontario, CanadaActive, not recruiting
Centre de recherche du CISSS de Chaudière-Appalaches - Hôpital Hôtel Dieu de Levis ( Site 0011)Lévis, Quebec, CanadaRecruiting
Centre Hospitalier de l'Université de Montréal - Gastroenterology ( Site 0013)Montreal, Quebec, CanadaRecruiting
Montreal General Hospital ( Site 0003)Montreal, Quebec, CanadaRecruiting
Diex Recherche Quebec ( Site 0008)Québec, Quebec, CanadaCompleted
Hospital hernan henriquez aravena de temuco ( Site 2607)Temuco, Araucania, ChileRecruiting
Hospital Clínico Regional Dr. Guillermo Grant Benavente ( Site 2604)Concepción, Biobio, ChileRecruiting
Clínica Universidad de Los Andes ( Site 2609)Las Condes, Region M. de Santiago, ChileRecruiting
FALP-UIDO ( Site 2600)Santiago, Region M. de Santiago, ChileRecruiting
Clínica Alemana de Santiago-Unidad de Investigaciones ( Site 2602)Santiago, Region M. de Santiago, ChileRecruiting
Espacio Eme ( Site 2608)Santiago, Region M. de Santiago, ChileRecruiting
CECIM ( Site 2603)Santiago, Region M. de Santiago, ChileRecruiting
Centro de Investigaciones Clinicas Vina del Mar ( Site 2606)Viña del Mar, Valparaiso, ChileRecruiting
Anhui Provincial Hospital ( Site 3922)Hefei, Anhui, ChinaRecruiting
Peking University Third Hospital ( Site 3910)Beijing, Beijing Municipality, ChinaRecruiting
Chongqing General Hospital ( Site 3940)Chongqing, Chongqing Municipality, ChinaRecruiting
The First Affiliated Hospital Of Fujian Medical University ( Site 3916)Fuzhou, Fujian, ChinaRecruiting
The First Affiliated hospital of Xiamen University ( Site 3924)Xiamen, Fujian, ChinaRecruiting
Zhongshan Hospital Affiliated to Xiamen University ( Site 3923)Xiamen, Fujian, ChinaRecruiting
Dongguan People's Hospital ( Site 3933)Dongguan, Guangdong, ChinaRecruiting
The First Affiliated Hospital, Sun Yat-sen University ( Site 3901)Guangzhou, Guangdong, ChinaRecruiting
The Sixth Affiliated Hospital of Sun Yat-sen University ( Site 3907)Guangzhou, Guangdong, ChinaRecruiting
Huizhou Municipal Central Hospital ( Site 3915)Huizhou, Guangdong, ChinaRecruiting
Yuebei People's Hospital ( Site 3912)Shaoguan, Guangdong, ChinaRecruiting
The University of Hong Kong-Shenzhen Hospital ( Site 3930)Shenzhen, Guangdong, ChinaRecruiting
Shenzhen Hospital of Southern Medical University ( Site 3932)Shenzhen, Guangdong, ChinaRecruiting
The Second Afilliated Hospital of Hebei Medical University ( Site 3913)Shijiazhuang, Hebei, ChinaRecruiting
The Second Affiliated Hospital of Zhengzhou University ( Site 3909)Zhengzhou, Henan, ChinaRecruiting
Taihe Hospital ( Site 3944)Shiyan, Hubei, ChinaRecruiting
Renmin Hospital of Wuhan University ( Site 3921)Wuhan, Hubei, ChinaRecruiting
The Second Xiangya Hospital of Central South University-gastroenterology department ( Site 3905)Changsha, Hunan, ChinaRecruiting
Huai'an First People's Hospital ( Site 3948)Huaian, Jiangsu, ChinaRecruiting
Nanjing Drum Tower Hospital The Affiliated Hospital of Nanjing University Medical School ( Site 3937)Nanjing, Jiangsu, ChinaRecruiting
Zhongda Hospital Southeast University-Gastroenterology ( Site 3911)Nanjing, Jiangsu, ChinaRecruiting
Wuxi People's Hospital ( Site 3925)Wuxi, Jiangsu, ChinaRecruiting
Yangzhou University Affiliated Hospital ( Site 3947)Yangzhou, Jiangsu, ChinaRecruiting
Affiliated Hospital of Jiangsu University ( Site 3919)Zhenjiang, Jiangsu, ChinaRecruiting
Changzhou No.2 People's Hospital ( Site 3904)Zhenjiang, Jiangsu, ChinaRecruiting
Tangdu Hospital of Fourth Military Medical University of Chinese People's Liberation Army ( Site 3918)Xi'an, Shaanxi, ChinaCompleted
Ruijin Hospital Shanghai Jiaotong University School of Medicine ( Site 3931)Shanghai, Shanghai Municipality, ChinaRecruiting
Huashan Hospital of Fudan University ( Site 3946)Shanghai, Shanghai Municipality, ChinaRecruiting
Shanghai East Hospital ( Site 3914)Shanghai, Shanghai Municipality, ChinaRecruiting
West China Hospital, Sichuan University ( Site 3929)Chengdu, Sichuan, ChinaRecruiting
Suining Central Hospital ( Site 3927)Suining, Sichuan, ChinaCompleted
First Affiliated Hospital of Kunming Medical University ( Site 3928)Kunming, Yunnan, ChinaRecruiting
Sir Run Run Shaw Hospital of Zhejiang University School of Medicine-GI Medicine ( Site 3902)Hangzhou, Zhejiang, ChinaRecruiting
Taizhou Hospital of Zhejiang Province ( Site 3936)Taizhou, Zhejiang, ChinaRecruiting
Salud SURA Industriales ( Site 2706)Medellín, Antioquia, ColombiaRecruiting
Clinica Medellin S.A ( Site 2705)Medellín, Antioquia, ColombiaRecruiting
Fundacion Santa Fe de Bogota ( Site 2703)Bogotá, Cundinamarca, ColombiaRecruiting
IMAT S.A.S ( Site 2700)Montería, Departamento de Córdoba, ColombiaRecruiting
Oncologos del Occidente ( Site 2702)Pereira, Risaralda Department, ColombiaRecruiting
Fundación Valle del Lili ( Site 2704)Cali, Valle del Cauca Department, ColombiaRecruiting
Klinička bolnica Merkur ( Site 0503)Zagreb, City of Zagreb, CroatiaCompleted
Klinički bolnički centar Zagreb ( Site 0501)Zagreb, City of Zagreb, CroatiaCompleted
Poliklinika Bates ( Site 0504)Zagreb, City of Zagreb, CroatiaRecruiting
Poliklinika Solmed ( Site 0502)Zagreb, City of Zagreb, CroatiaRecruiting
Poliklinika Borzan ( Site 0500)Osijek, County of Osijek-Baranja, CroatiaRecruiting
Pratia Czech s.r.o. ( Site 0657)Brno, Brno-mesto, CzechiaRecruiting
Vojenská Nemocnice Brno-Internal department ( Site 0655)Brno, Brno-mesto, CzechiaRecruiting
Nemocnice Slany-Gastroenterologicka a Endoskopicka ambulance ( Site 0651)Slaný, Central Bohemia, CzechiaRecruiting
Institut Klinicke a Experimentalni Mediciny-Klinika hepatogastroentrologie ( Site 0654)Prague, Praha 4, CzechiaRecruiting
Hepato-Gastroenterologie HK ( Site 0652)Hradec Králové, CzechiaRecruiting
ISCARE klinické centrum ( Site 0656)Prague, CzechiaRecruiting
Herlev and Gentofte Hospital ( Site 5300)Copenhagen, Capital Region, DenmarkRecruiting
Odense Universitetshospital ( Site 5301)Odense C, Region Syddanmark, DenmarkRecruiting
CEMDOE - Centro Médico de Diabetes, Obesidad y Especialidades ( Site 2901)Santo Domingo, Nacional, Dominican RepublicRecruiting
Tampereen yliopistollinen sairaala ( Site 5401)Tampere, Pirkanmaa, FinlandRecruiting
Pohjois-Karjalan Keskussairaala ( Site 5403)Joensuu, Pohjois-Karjala, FinlandRecruiting
Turku University Hospital ( Site 5402)Turku, Southwest Finland, FinlandRecruiting
Centre Hospitalier Universitaire de Nice - Hôpital l'Archet ( Site 0711)Nice, Alpes-Maritimes, FranceRecruiting
CHU Bordeaux Haut-Leveque ( Site 0713)Pessac, Aquitaine, FranceRecruiting
Assistance Publique Hôpitaux de Marseille - Hôpital Nord ( Site 0722)Marseille, Bouches-du-Rhone, FranceRecruiting
Centre Hospitalier Universitaire Dijon Bourgogne - Hôpital François Mitterrand ( Site 0708)Dijon, Bourgogne-Franche-Comté, FranceRecruiting
Centre Hospitalier Universitaire de Reims - Hôpital Robert Debré ( Site 0707)Reims, Champagne-Ardenne, FranceCompleted
CHU Besançon ( Site 0724)Besançon, Doubs, FranceRecruiting
Centre Hospitalier de Valence ( Site 0725)Valence, Drome, FranceCompleted
C.H.U. de Nimes. Hopital Caremeau ( Site 0731)Nîmes, Gard, FranceRecruiting
CHU Rangueil ( Site 0710)Toulouse, Haute-Garonne, FranceRecruiting
Hopital Beaujon ( Site 0729)Clichy, Hauts-de-Seine, FranceRecruiting
CMC Ambroise Paré Hartmann - Institut des MICI ( Site 0723)Neuilly-sur-Seine, Hauts-de-Seine, FranceRecruiting
Clinique des Cèdres ( Site 0732)Échirolles, Isere, FranceRecruiting
CHU SAINT ELOI ( Site 0701)Montpellier, Languedoc-Roussillon, FranceActive, not recruiting
Centre Hospitalier Universitaire de Nantes - L' Hopital l'hôtel-Dieu ( Site 0705)Nantes, Loire-Atlantique, FranceRecruiting
Centre Hospitalier Régional Universitaire de Nancy - Hôpitaux de Brabois ( Site 0717)Vandœuvre-lès-Nancy, Meurthe-et-Moselle, FranceRecruiting
Hopital Claude Huriez - CHU de Lille ( Site 0715)Lille, Nord, FranceRecruiting
centre hospitalier lyon sud ( Site 0716)Pierre-Bénite, Rhone, FranceRecruiting
CHU d'Amiens-Picardie - Hôpital Sud ( Site 0709)Amiens, Somme, FranceRecruiting
Hopital Henri Mondor ( Site 0730)Créteil, Val-de-Marne, FranceRecruiting
Hôpital Saint Antoine ( Site 0721)Paris, FranceRecruiting
Hôpitaux Universitaires Paris Sud - Hôpital Bicêtre ( Site 0702)Le Kremlin-Bicêtre, Île-de-France Region, FranceCompleted
LTD High Technology Hospital Medcenter ( Site 0802)Batumi, Adjara, GeorgiaRecruiting
Caucasus Medical Centre ( Site 0801)Tbilisi, Adjara, GeorgiaRecruiting
New Hospitals ( Site 0800)Tbilisi, GeorgiaRecruiting
Caraps Medline ( Site 0803)Tbilisi, GeorgiaRecruiting
Siloah St. Trudpert Klinikum-Zentrum für Innere Medizin ( Site 0992)Pforzheim, Baden-Wurttemberg, GermanyRecruiting
Klinikum der Universität München Großhadern ( Site 0990)München, Bavaria, GermanyRecruiting
klinikum rechts der isar der technischen universität münchen ( Site 0989)München, Bavaria, GermanyRecruiting
Universitaetsklinikum Ulm. ( Site 0994)Ulm, Bavaria, GermanyRecruiting
Medizinische Hochschule Hannover ( Site 0999)Hanover, Lower Saxony, GermanyRecruiting
Klinikum Lüneburg ( Site 0991)Lüneburg, Lower Saxony, GermanyRecruiting
Universitätsmedizin Rostock ( Site 0993)Rostock, Mecklenburg-Vorpommern, GermanyRecruiting
Evangelisches Krankenhaus Kalk gGmbH ( Site 0986)Cologne, North Rhine-Westphalia, GermanyCompleted
Stadtische Kliniken Duisburg, Abtlg. Innere Medizin ( Site 0985)Duisburg, North Rhine-Westphalia, GermanyRecruiting
Gastroenterologische Gemeinschaftspraxis Minden ( Site 0998)Minden, North Rhine-Westphalia, GermanyRecruiting
Medizinisches Versorgungszentrum Portal 10 ( Site 0988)Münster, North Rhine-Westphalia, GermanyCompleted
Magen Darm Zentrum Remscheid ( Site 0984)Remscheid, North Rhine-Westphalia, GermanyRecruiting
St. Marien und St. Annastift Krankenhaus ( Site 0987)Ludwighafen Am Rhein, Rhineland-Palatinate, GermanyRecruiting
Universitätsklinikum Leipzig ( Site 0997)Leipzig, Saxony, GermanyRecruiting
Universitaetsklinikum Schleswig-Holstein Campus Kiel ( Site 0995)Kiel, Schleswig-Holstein, GermanyRecruiting
Charité Campus Virchow-Klinikum ( Site 0996)Berlin, GermanyRecruiting
Universitätsklinikum Brandenburg an der Havel ( Site 0903)Brandenburg, GermanyRecruiting
Evangelismos General Hospital of Athens ( Site 1002)Athens, Attica, GreeceRecruiting
THORACIC GENERAL HOSPITAL OF ATHENS "I SOTIRIA"-3rd Dept of Internal Medicine and Laboratory, Oncol ( Site 1004)Athens, Attica, GreeceRecruiting
General Hospital of Nikaia-Piraeus "Agios Panteleimon" ( Site 1003)Nikaia Piraeus, Attica, GreeceRecruiting
Ippokrateio General Hospital of Thessaloniki ( Site 1001)Thessaloniki, Central Macedonia, GreeceRecruiting
University General Hospital of Heraklion-GASTROENTEROLOGY & HEPATOLOGY ( Site 1000)Heraklion, Crete, GreeceRecruiting
Queen Mary Hospital ( Site 3300)Hksar, Hong KongRecruiting
Békés Megyei Központi Kórház Dr. Réthy Pál Tagkórház-4. Belgyogyaszat Gasztroenterologia ( Site 1105)Békéscsaba, Bekescsaba, HungaryRecruiting
Heves Vármegyei Markhot Ferenc Oktatókórház és Rendelőintézet ( Site 1117)Eger, Heves County, HungaryCompleted
Gyöngyösi Bugát Pál Kórház ( Site 1111)Gyöngyös, Heves County, HungaryRecruiting
Komarom-Esztergom Varmegyei Szent Borbala Korhaz ( Site 1115)Tatabánya, Komárom-Esztergom, HungaryRecruiting
VeszLife Magánklinika ( Site 1102)Veszprém, Veszprém megye, HungaryRecruiting
Clinexpert Kft.-Clinexpert Budapest ( Site 1108)Budapest, HungaryRecruiting
Synexus Magyarorszag Kft. (Budapest DRS) ( Site 1107)Budapest, HungaryCompleted
Semmelweis Egyetem ( Site 1118)Budapest, HungaryRecruiting
Eszak-Pesti Centrumkorhaz-Honvedkorhaz ( Site 1100)Budapest, HungaryCompleted
Pannónia Magánorvosi Centrum ( Site 1103)Budapest, HungaryRecruiting
Beaumont Hospital, Dublin ( Site 5601)Dublin, IrelandCompleted
Emek Medical Center ( Site 1206)Afula, IsraelRecruiting
Barzilai Medical Center ( Site 1209)Ashkelon, IsraelRecruiting
Rambam Health Care Campus ( Site 1201)Haifa, IsraelRecruiting
Bnai Zion Medical Center ( Site 1203)Haifa, IsraelRecruiting
Edith Wolfson Medical Center ( Site 1204)Holon, IsraelRecruiting
Shaare Zedek Medical Center ( Site 1208)Jerusalem, IsraelRecruiting
Meir Medical Center. ( Site 1202)Kfar Saba, IsraelRecruiting
Rabin Medical Center ( Site 1207)Petah Tikva, IsraelRecruiting
Sheba Medical Center ( Site 1200)Ramat Gan, IsraelRecruiting
A.O.U.C. Policlinico di Bari ( Site 1306)Bari, Apulia, ItalyRecruiting
Policlinico Universitario Monserrato-SC Gastroenterologia ( Site 1313)Monserrato, Cagliari, ItalyRecruiting
Fondazione Policlinico Tor Vergata ( Site 1307)Rome, Lazio, ItalyActive, not recruiting
Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico-Gastroenterology and Endoscopy Unit ( Site 1304)Milan, Lombardy, ItalyRecruiting
Istituto Clinico Humanitas-IBD center ( Site 1309)Rozzano, Lombardy, ItalyRecruiting
A.O.R.N. Ospedale dei Colli - Monaldi V. ( Site 1310)Naples, Napoli, ItalyRecruiting
Ospedale Mauriziano - Gastroenterology Unit ( Site 9000)Turin, Piedmont, ItalyRecruiting
Ospedale "Felice Lotti" Di Pontedera ( Site 1311)Pontedera, Pisa, ItalyRecruiting
Az. Osp. Ospedali Riuniti VILLA SOFIA-CERVELLO-U.O.S.D. Malattie Infiammatorie Croniche Intestinali ( Site 1302)Palermo, Sicily, ItalyRecruiting
Azienda Ospedaliera Universitaria Careggi-MICI ( Site 9002)Florence, Tuscany, ItalyRecruiting
Ospedale Sacro Cuore Don G. Calabria-IBD Unit ( Site 1303)Negrar, Verona, ItalyRecruiting
IRCCS Azienda Ospedaliero-Universitaria di Bologna, Policlinico di Sant'Orsola ( Site 1308)Bologna, ItalyRecruiting
Azienda Ospedaliera Universitaria Di Messina G. Martino ( Site 1314)Messina, ItalyRecruiting
Ospedale San Raffaele-Gastroenterology and Gastrointestinal Endoscopy ( Site 1300)Milan, ItalyRecruiting
Fondazione Policlinico Universitario Agostino Gemelli IRCCS -Dipartimento di Medicina Interna e Gas ( Site 1312)Roma, ItalyRecruiting
Aichi Medical University Hospital ( Site 3429)Nagakute, Aichi-ken, JapanCompleted
Nagoya University Hospital ( Site 3445)Nagoya, Aichi-ken, JapanRecruiting
Nagoya City University Hospital ( Site 3446)Nagoya, Aichi-ken, JapanCompleted
Tokatsu Tsujinaka Hospital ( Site 3403)Abiko, Chiba, JapanRecruiting
Tsujinaka Hospital - Kashiwanoha ( Site 3402)Kashiwa, Chiba, JapanRecruiting
Toho University Sakura Medical Center ( Site 3413)Sakura, Chiba, JapanRecruiting
Kurume University Hospital ( Site 3419)Kurume, Fukuoka, JapanRecruiting
Gunma University Hospital ( Site 3432)Maebashi, Gunma, JapanRecruiting
National Hospital Organization Fukuyama Medical Center ( Site 3442)Fukuyama, Hiroshima, JapanCompleted
Sapporo Tokushukai Hospital ( Site 3427)Sapporo, Hokkaido, JapanActive, not recruiting
Sapporo Medical University Hospital ( Site 3460)Sapporo, Hokkaido, JapanCompleted
Medical Corporation Sapporo IBD Clinic ( Site 3420)Sapporo, Hokkaido, JapanActive, not recruiting
Sapporohigashi Tokushukai Hospital ( Site 3441)Sapporo, Hokkaido, JapanRecruiting
Hyogo Medical University Hospital ( Site 3430)Nishinomiya, Hyōgo, JapanRecruiting
Hitachi General Hospital ( Site 3438)Hitachi, Ibaraki, JapanRecruiting
Tsuchiura Kyodo General Hospital ( Site 3463)Tsuchiura, Ibaraki, JapanCompleted
Tsukuba Memorial Hospital ( Site 3461)Tsukuba, Ibaraki, JapanCompleted
Kanazawa University Hospital ( Site 3436)Kanazawa, Ishikawa-ken, JapanRecruiting
Iwate Medical University Hospital ( Site 3457)Shiwa-gun, Iwate, JapanRecruiting
Gokeikai Ofuna Chuo Hospital ( Site 3412)Kamakura, Kanagawa, JapanRecruiting
St. Marianna University Hospital ( Site 3440)Kawasaki, Kanagawa, JapanRecruiting
Matsushima Hospital ( Site 3450)Yokohama, Kanagawa, JapanRecruiting
Yokohama City University Medical Center ( Site 3439)Yokohama, Kanagawa, JapanRecruiting
Mie University Hospital ( Site 3405)Tsu, Mie-ken, JapanCompleted
Tohoku University Hospital ( Site 3447)Sendai, Miyagi, JapanRecruiting
University of the Ryukyus Hospital ( Site 3459)Ginowan, Okinawa, JapanRecruiting
Kansai Medical University Hospital ( Site 3409)Hirakata, Osaka, JapanRecruiting
Saitama Medical Center ( Site 3452)Kawagoe, Saitama, JapanRecruiting
Hamamatsu University Hospital ( Site 3449)Hamamatsu, Shizuoka, JapanRecruiting
Matsuda Hospital ( Site 3404)Hamamatsu, Shizuoka, JapanRecruiting
National Hospital Organization Shizuoka Medical Center ( Site 3401)Shimizu, Shizuoka, JapanRecruiting
Institute of Science Tokyo Hospital ( Site 3437)Bunkyō, Tokyo, JapanRecruiting
Ginza Central Clinic ( Site 3407)Chūō, Tokyo, JapanCompleted
Kitasato University Kitasato Institute Hospital ( Site 3458)Minato, Tokyo, JapanRecruiting
Toranomon Hospital ( Site 3433)Minato-ku, Tokyo, JapanRecruiting
Kyorin University Hospital ( Site 3443)Mitaka, Tokyo, JapanRecruiting
The Jikei University Hospital ( Site 3414)Mitato, Tokyo, JapanRecruiting
Tokyo Medical University Hospital ( Site 3456)Shinjuku, Tokyo, JapanRecruiting
National Center for Global Health and Medicine ( Site 3423)Shinjuku, Tokyo, JapanRecruiting
Yamanashi Prefectural Central Hospital ( Site 3435)Kofu, Yamanashi, JapanRecruiting
Fukuoka University Hospital ( Site 3417)Fukuoka, JapanRecruiting
Japanese Red Cross Fukuoka Hospital ( Site 3462)Fukuoka, JapanCompleted
Hiroshima University Hospital ( Site 3418)Hiroshima, JapanRecruiting
Kagoshima University Hospital ( Site 3425)Kagoshima, JapanCompleted
Kagoshima IBD Gastroenterology Clinic ( Site 3428)Kagoshima, JapanRecruiting
Coloproctology Center Takano Hospital ( Site 3466)Kumamoto, JapanRecruiting
University Hospital,Kyoto Prefectural University of Medicine ( Site 3406)Kyoto, JapanRecruiting
National Hospital Organization Kyoto Medical Center ( Site 3411)Kyoto, JapanRecruiting
Okayama University Hospital ( Site 3454)Okayama, JapanCompleted
Kinshukai Grand Front Osaka Medical Clinic ( Site 3408)Osaka, JapanRecruiting
National Hospital Organization Osaka National Hospital ( Site 3453)Osaka, JapanRecruiting
Saga University Hospital ( Site 3424)Saga, JapanActive, not recruiting
Tokyo Yamate Medical Center ( Site 3415)Tokyo, JapanRecruiting
Toyama Prefectural Central Hospital ( Site 3410)Toyama, JapanRecruiting
Yamagata University Hospital ( Site 3426)Yamagata, JapanRecruiting
Pauls Stradins Clinical University Hospital ( Site 5903)Riga, LatviaRecruiting
SIA M & M Centrs ( Site 5902)Adazi, Ādaži, LatviaRecruiting
Hospital of Lithuanian University of Health Sciences Kauno klinikos-Gastroenterology ( Site 6000)Kaunas, Kaunas County, LithuaniaRecruiting
VILNIUS UNIVERSITY HOSPITAL SANTAROS KLINIKOS-Department of Clinical Trials and Pharmacology ( Site 6001)Vilnius, LithuaniaRecruiting
Hospital Sultanah Aminah ( Site 6104)Johor Bahru, Johor, MalaysiaRecruiting
Hospital Universiti Sains Malaysia ( Site 6103)Kubang Kerian, Kelantan, MalaysiaRecruiting
University Malaya Medical Centre ( Site 6101)Lembah Pantai, Kuala Lumpur, MalaysiaRecruiting
Sarawak General Hospital ( Site 6102)Kuching, Sarawak, MalaysiaRecruiting
Hospital Ampang ( Site 6106)Ampang, Selangor, MalaysiaRecruiting
Morales Vargas Centro de Investigacion S. C. ( Site 3101)León, Guanajuato, MexicoRecruiting
Centro Medico Clinico Quirurgico Especializado en Investigación ( Site 3106)Tlajomulco de Zúñiga, Jalisco, MexicoRecruiting
Centro de Investigación y Gastroenterología - S.C. ( Site 3102)Benito Juarez Ciudad de Mexico, Mexico City, MexicoRecruiting
Medica Sur-Clinica de Enfermedades Digestivas y Obesidad ( Site 3104)Mexico City, Mexico City, MexicoCompleted
JM Research SC ( Site 3109)Cuernavaca, Morelos, MexicoRecruiting
Hospital Universitario "Dr. Jose Eleuterio Gonzalez"-Gastroenterología ( Site 3100)Monterrey, Nuevo León, MexicoRecruiting
Servicios de Oncología Médica Integral, S.A de C.V. ( Site 3108)San Pedro Garza García, Nuevo León, MexicoRecruiting
Centro de Investigacion Clinica de Oaxaca ( Site 3105)Oaxaca City, Oaxaca, MexicoRecruiting
Medical Care and Research SA de CV-GASTROENTEROLOGY ( Site 3110)Mérida, Yucatán, MexicoRecruiting
Scientia Investigacion Clinica S.C. ( Site 3114)Chihuahua City, MexicoRecruiting
Radboudumc ( Site 1505)Nijmegen, Gelderland, NetherlandsRecruiting
ETZ Elisabeth ( Site 1501)Tilburg, North Brabant, NetherlandsRecruiting
Ziekenhuis Bernhoven ( Site 1508)Uden, North Brabant, NetherlandsRecruiting
Amsterdam UMC, locatie VUmc-IBD Trial Unit ( Site 1500)Amsterdam, North Holland, NetherlandsRecruiting
Erasmus Medisch Centrum ( Site 1504)Rotterdam, South Holland, NetherlandsRecruiting
Franciscus Gasthuis & Vlietland, Locatie Gasthuis ( Site 1503)Rotterdam, South Holland, NetherlandsRecruiting
University Medical Center Groningen ( Site 1506)Groningen, NetherlandsRecruiting
Universitair Medisch Centrum Utrecht ( Site 1502)Utrecht, NetherlandsRecruiting
Dunedin Hospital ( Site 3505)Dunedin, Otago, New ZealandRecruiting
Hutt Valley District Health board HVDHB ( Site 3500)Lower Hutt, Wellington Region, New ZealandRecruiting
Aotearoa Clinical Trials ( Site 3501)Auckland, New ZealandRecruiting
Investigaciones Clínicas / Instituto de Ginecología y Reproducción ( Site 3002)Lima, PeruRecruiting
Hospital Cayetano Heredia ( Site 3003)Lima, PeruRecruiting
Hospital Nacional Edgardo Rebagliati Martins-Aparato Digestivo ( Site 0154)Lima, PeruRecruiting
Pratia S.A. Pratia Poznan ( Site 1603)Poznan, Greater Poland Voivodeship, PolandRecruiting
EMC Instytut Medyczny S.A,Prywatna Lecznica Certus Ambulatoria,Prywatna Lecznica Certus Szpital Nr1 ( Site 1605)Poznan, Greater Poland Voivodeship, PolandRecruiting
Twoja Przychodnia Poznanskie Centrum Medyczne Sp. z o.o.,Twoja Przychodnia PCM ( Site 1632)Poznan, Greater Poland Voivodeship, PolandRecruiting
NZOZ Centrum Medyczne KERmed ( Site 1641)Bydgoszcz, Kuyavian-Pomeranian Voivodeship, PolandRecruiting
Gastromed Sp. z o. o. ( Site 1619)Torun, Kuyavian-Pomeranian Voivodeship, PolandRecruiting
Centrum Medyczne Plejady ( Site 1627)Krakow, Lesser Poland Voivodeship, PolandRecruiting
FutureMeds Krakow ( Site 1628)Krakow, Lesser Poland Voivodeship, PolandRecruiting
PROMED P. LACH R. GLOWACKI SP. J. ( Site 1636)Krakow, Lesser Poland Voivodeship, PolandRecruiting
Allmedica ( Site 1602)Nowy Targ, Lesser Poland Voivodeship, PolandRecruiting
Medicome Sp. z o.o ( Site 1635)Oświęcim, Lesser Poland Voivodeship, PolandRecruiting
Amicare ( Site 1620)Jelenia Góra, Lower Silesian Voivodeship, PolandActive, not recruiting
Planetmed ( Site 1600)Wroclaw, Lower Silesian Voivodeship, PolandRecruiting
Vistamed & Vertigo Sp. z o.o. ( Site 1621)Wroclaw, Lower Silesian Voivodeship, PolandRecruiting
Melita Medical Sp. z o.o. ( Site 1607)Wroclaw, Lower Silesian Voivodeship, PolandRecruiting
Penta Hospitals Przychodnie Wrocław Wejherowska ( Site 1601)Wroclaw, Lower Silesian Voivodeship, PolandRecruiting
Medrise Sp. z o.o. ( Site 1626)Lublin, Lublin Voivodeship, PolandRecruiting
Uniwersytecki Szpital Kliniczny nr 4 w Lublinie, Kliniczny Oddział Gastroenterologii, Hepatologii i ( Site 1615)Lublin, Lublin Voivodeship, PolandRecruiting
ETG Zamosc ( Site 1631)Zamość, Lublin Voivodeship, PolandRecruiting
EB Group Sp. Z o.o. Centrum Zdrowia MDM ( Site 1618)Warsaw, Masovian Voivodeship, PolandRecruiting
ETG Warszawa ( Site 1629)Warsaw, Masovian Voivodeship, PolandRecruiting
Narodowy Instytut Onkologii im. Marii Sklodowskiej-Curie - P-Klinika Gastroenterologii Onkologiczne ( Site 1624)Warsaw, Masovian Voivodeship, PolandRecruiting
Vivamed Sp. z o.o. ( Site 1623)Warsaw, Masovian Voivodeship, PolandRecruiting
WIP Warsaw IBD Point Profesor Kierkuś ( Site 1622)Warsaw, Masovian Voivodeship, PolandRecruiting
Twoja Przychodnia Opolskie Centrum Medyczne ( Site 1633)Opole, Opole Voivodeship, PolandRecruiting
Endoskopia Sp. z.o.o. ( Site 1637)Sopot, Pomeranian Voivodeship, PolandRecruiting
M2M ( Site 1630)Chorzów, Silesian Voivodeship, PolandRecruiting
H-T Centrum Medyczne Endoterapia ( Site 1610)Tychy, Silesian Voivodeship, PolandRecruiting
Twoja Przychodnia - Szczecinskie Centrum Medyczne ( Site 1612)Szczecin, West Pomeranian Voivodeship, PolandRecruiting
Sonomed Sp. z o. o. ( Site 1617)Szczecin, West Pomeranian Voivodeship, PolandRecruiting
IP Clinic ( Site 1638)Lodz, Łódź Voivodeship, PolandRecruiting
Centrum Medyczne Med-Gastr Sp. z o.o. ( Site 1616)Lodz, Łódź Voivodeship, PolandRecruiting
AmiCare Sp. z o.o. Sp. k. ( Site 1608)Lodz, Łódź Voivodeship, PolandRecruiting
Unidade Local de Saúde do Alto Ave - Hospital Senhora da Oliveira ( Site 1704)Guimarães, Braga District, PortugalRecruiting
Unidade Local de Saude do Algarve - Hospital de Portimão ( Site 1700)Portimão, Faro District, PortugalRecruiting
Unidade Local de Saude da Região de Leiria - Hospital Santo André ( Site 1706)Leiria, PortugalRecruiting
Hospital da Luz Lisboa ( Site 1707)Lisbon, PortugalRecruiting
Hospital dos Lusíadas Lisboa ( Site 1701)Lisbon, PortugalRecruiting
ULSAM - Hospital de Santa Luzia ( Site 1703)Viana do Castelo, PortugalRecruiting
Unidade Local de Saude Dão-Lafões - Hospital de São Teotónio ( Site 1702)Viseu, PortugalRecruiting
MEMORIAL HEALTHCARE INTERNATIONAL S.R.L ( Site 1806)Bucharest, Bucharest, RomaniaRecruiting
Fundeni Clinical Institute-Gastroenterology and Hepatology Center ( Site 1808)Bucharest, Bucharest, RomaniaRecruiting
GastroMed ( Site 1809)Cluj-Napoca, Cluj, RomaniaRecruiting
Spitalul Clinic Judetean Mures-Gastroenterology ( Site 1807)Târgu Mureş, Mureș County, RomaniaRecruiting
ASOCIATIA ONCOHELP ( Site 1805)Timișoara, Timiș County, RomaniaRecruiting
Monza Ares SRL ( Site 1804)Bucharest, RomaniaRecruiting
King Abdullah Medical City Specialist Hospital ( Site 5230)Mecca, Makkah Al Mukarramah, Saudi ArabiaRecruiting
King Abdul Aziz Medical City - AlRiyadh ( Site 5210)Riyadh, Riyadh Region, Saudi ArabiaRecruiting
King Saud University Medical City ( Site 5220)Riyadh, Riyadh Region, Saudi ArabiaRecruiting
King Faisal Specialist Hospital and Research Center ( Site 5200)Riyadh, Riyadh Region, Saudi ArabiaRecruiting
Clinical Hospital Center Dragisa Misovic ( Site 1906)Belgrade, Beograd, SerbiaRecruiting
Clinical Hospital Center Zvezdara-Gastroenterology and hepatology Department ( Site 1903)Belgrade, Beograd, SerbiaRecruiting
University Medical Center "Bezanijska kosa"-Gastroenterology and hepatology ( Site 1900)Belgrade, Beograd, SerbiaRecruiting
Zemun Medical Centre ( Site 1910)Zemun, Beograd, SerbiaRecruiting
General Hospital "Djordje Joanovic" ( Site 1905)Zrenjanin, Srednjebanatski Okrug, SerbiaRecruiting
Clinical Center Kragujevac ( Site 1904)Kragujevac, Sumadijski Okrug, SerbiaRecruiting
Singapore General Hospital ( Site 6202)Singapore, Central Singapore, SingaporeRecruiting
Tan Tock Seng Hospital-Gastroenterology and Hepatology ( Site 6201)Singapore, Central Singapore, SingaporeRecruiting
Changi General Hospital ( Site 6203)Singapore, South East, SingaporeCompleted
Fakultna nemocnica s poliklinikou F.D.Roosevelta Banska Bystrica-Gastroenterologicke oddelenie ( Site 2002)Banská Bystrica, Banská Bystrica Region, SlovakiaRecruiting
Cliniq s.r.o. ( Site 2001)Bratislava, Bratislava Region, SlovakiaCompleted
KM Management ( Site 2000)Nitra, Nitra Region, SlovakiaRecruiting
GASTRO I ( Site 2004)Prešov, Presov, SlovakiaRecruiting
Gastro LM ( Site 2005)Prešov, Presov, SlovakiaRecruiting
Wits Clinical Research ( Site 4004)Johannesburg, Gauteng, South AfricaRecruiting
Wits Clinical Research-Chris Hani Baragwanath Hospital ( Site 4005)Soweto, Gauteng, South AfricaRecruiting
Panorama Medical Centre ( Site 4001)Cape Town, Western Cape, South AfricaRecruiting
Spoke Research ( Site 4003)Cape Town, Western Cape, South AfricaRecruiting
Life Kingsbury Hospital ( Site 4000)Cape Town, Western Cape, South AfricaRecruiting
Private Practice - Dr. M.N. Rajabally ( Site 4007)Plumstead, Western Cape, South AfricaRecruiting
Wonju Severance Christian Hospital-Internal Medicine ( Site 3600)Wŏnju, Kang-won-do, South KoreaRecruiting
Korea University Ansan Hospital ( Site 3617)Ansan-si, Kyonggi-do, South KoreaRecruiting
The Catholic University Of Korea St. Vincent's Hospital-Gastroenterology ( Site 3608)Suwon, Kyonggi-do, South KoreaCompleted
Dong-A University Hospital ( Site 3601)Busan, Pusan-Kwangyokshi, South KoreaRecruiting
Inje University Haeundae Paik Hospital ( Site 3605)Haeundae-gu, Pusan-Kwangyokshi, South KoreaRecruiting
Chung-Ang University Hospital ( Site 3606)Dongjak-gu, Seoul, South KoreaRecruiting
Kyungpook National Univ.Hospital ( Site 3616)Daegu, Taegu-Kwangyokshi, South KoreaRecruiting
Yeungnam Univeristy Medical Center ( Site 3610)Daegu, Taegu-Kwangyokshi, South KoreaRecruiting
Keimyung University Dongsan Medical Center ( Site 3614)Daegu, Taegu-Kwangyokshi, South KoreaRecruiting
The Catholic University of Korea, Daejeon St. Mary's Hospital ( Site 3604)Daejeon, Taejon-Kwangyokshi, South KoreaRecruiting
Kyung Hee University Hospital ( Site 3611)Seoul, South KoreaRecruiting
Seoul National University Hospital ( Site 3607)Seoul, South KoreaRecruiting
Kangbuk Samsung Hospital-Internal Medicine ( Site 3612)Seoul, South KoreaRecruiting
The Catholic University of Korea, Eunpyeong St. Mary's Hospital ( Site 3602)Seoul, South KoreaRecruiting
Severance Hospital, Yonsei University Health System-Department of Internal Medicine ( Site 3603)Seoul, South KoreaRecruiting
Asan Medical Center ( Site 3609)Seoul, South KoreaRecruiting
Samsung Medical Center ( Site 3613)Seoul, South KoreaRecruiting
Hospital Germans Trias i Pujol ( Site 2101)Badalona, Barcelona, SpainRecruiting
HOSPITAL CLÍNIC DE BARCELONA-ICMDM - Clinical Institute of Digestive and Metabolic Diseases ( Site 2112)Barcelona, Catalonia, SpainRecruiting
Complejo Hospitalario Universitario de Ferrol ( Site 2114)A Coruña, La Coruna, SpainRecruiting
Hospital Universitario Puerta de Hierro ( Site 2102)Majadahonda, Madrid, SpainRecruiting
Hospital Universitario de Torrejón ( Site 2108)Torrejón de Ardoz, Madrid, SpainRecruiting
Hospital Universitario La Paz ( Site 2100)Madrid, SpainRecruiting
Hospital Montecelo. Complexo Hospitalario de Pontevedra ( Site 2107)Pontevedra, SpainRecruiting
Hospital Universitario Nuestra Senora de la Candelaria ( Site 2105)Santa Cruz de Tenerife, SpainRecruiting
HOSPITAL CLINICO DE VALENCIA-MEDICINA DIGESTIVA ( Site 2103)Valencia, SpainRecruiting
Hospital Universitari i Politecnic La Fe ( Site 2111)Valencia, SpainRecruiting
Hospital Universitario Miguel Servet ( Site 2104)Zaragoza, SpainRecruiting
Danderyds Sjukhus ( Site 5501)Danderyd, Stockholm County, SwedenRecruiting
Karolinska Universitetssjukhuset Solna ( Site 5500)Stockholm, Stockholm County, SwedenRecruiting
Universitetssjukhuset i Linköping ( Site 5502)Linköping, Östergötland County, SwedenRecruiting
University Hospital Basel-Gastroenterology and Hepatology ( Site 2204)Basel, Canton of Basel-City, SwitzerlandRecruiting
INTESTO-Gastroenterologische Praxis / Crohn-Colitis Zentrum Bern ( Site 2202)Bern, Canton of Bern, SwitzerlandRecruiting
Cantonal Hospital St.Gallen-Klinik für Gastroenterologie / Hepatologie ( Site 2201)Sankt Gallen, Canton of St. Gallen, SwitzerlandRecruiting
UniversitätsSpital Zürich-Gastroenterologie & Hepatologie ( Site 2200)Zurich, Canton of Zurich, SwitzerlandRecruiting
National Taiwan University BioMedical Park Hospital ( Site 3702)Zhubei, Hsinchu, TaiwanRecruiting
National Taiwan University Hospital-Internal Medicine ( Site 3700)Taipei, TaiwanRecruiting
Chang Gung Medical Foundation-Linkou Branch ( Site 3701)Taoyuan, TaiwanRecruiting
Ege Universitesi Hastanesi ( Site 2302)Bornova, İzmir, Turkey (Türkiye)Active, not recruiting
Hacettepe Universitesi Tip Fakultesi Hastanesi ( Site 2300)Ankara, Turkey (Türkiye)Recruiting
ANKARA UNIVERSITY IBNI SINA HOSPITAL-Gastroenterology ( Site 2303)Ankara, Turkey (Türkiye)Completed
Ankara Bilkent Şehir Hastanesi-Gastroenterology ( Site 2301)Ankara, Turkey (Türkiye)Recruiting
Antalya Egitim ve Arastırma Hastanesi ( Site 2304)Antalya, Turkey (Türkiye)Recruiting
Eskisehir Osmangazi University Faculty of Medicine ( Site 2308)Eskişehir, Turkey (Türkiye)Completed
Istanbul Universitesi Cerrahpasa Tip Fakultesi Hastanesi ( Site 2306)Istanbul, Turkey (Türkiye)Completed
Marmara Univetsitesi Pendik Egitim ve Arastirma Hastanesi ( Site 2305)Istanbul, Turkey (Türkiye)Recruiting
Kocaeli University Medical Faculty Hospital ( Site 2309)Kocaeli, Turkey (Türkiye)Recruiting
Communal non-profit enterprise "Regional clinical hospital of Ivano-Frankivsk Regional Council" ( Site 5815)Ivano-Frankivsk, Ivano-Frankivsk Oblast, UkraineRecruiting
Medical Center of Limited ( Site 5806)Kyiv, Kyivska Oblast, UkraineRecruiting
Center of Family Medicine Plus ( Site 5803)Kyiv, Kyivska Oblast, UkraineRecruiting
Communal Non-profit Enterprise of Lviv Regional Council "Lviv Regional Clinical Hospital"-proctology ( Site 5809)Lviv, Lviv Oblast, UkraineRecruiting
Limited liability company "Medical center Health Clinic" ( Site 5807)Vinnytsia, Vinnytsia Oblast, UkraineRecruiting
Municipal Nonprofit Enterprise "Vinnytsia Regional Clinical Hospital n.a. M. I. Pyrohov of Vinnytsia ( Site 5814)Vinnytsia, Vinnytsia Oblast, UkraineRecruiting
Clinic of Scientific and Research Institute of Invalid Rehabilitation of VNMU n.a. M.I.Pyrohov ( Site 5812)Vinnytsia, Vinnytsia Oblast, UkraineRecruiting
Communal Non-Commercial Enterprise "Vinnytsia City Clinical -Clinical Therapeutic Department #1 ( Site 5811)Vinnytsia, Vinnytsia Oblast, UkraineRecruiting
Municipal Enterprise "Volyn Regional Clinical Hospital" of Volyn Regional Council ( Site 5813)Lutsk, Volyn Oblast, UkraineRecruiting
Medical Center "Universal Clinic "Oberig" of Limited Liability Company "Kapytal" ( Site 5800)Kyiv, UkraineRecruiting
Dobrobut Medical Center ( Site 5801)Kyiv, UkraineRecruiting
Medical Center of Private Enterprise "Sygma" ( Site 5808)Kyiv, UkraineRecruiting
Addenbrooke's Hospital ( Site 2400)Cambridge, Cambridgeshire, United KingdomRecruiting
Royal Devon & Exeter Hospital ... ( Site 2407)Exeter, Devon, United KingdomActive, not recruiting
Doncaster Royal Infirmary ( Site 2401)Doncaster, England, United KingdomRecruiting
Huddersfield Royal Infirmary ( Site 2409)Huddersfield, England, United KingdomRecruiting
Whipps Cross University Hospital-Clinical Research Unit ( Site 2404)London, England, United KingdomRecruiting
Southampton General Hospital ( Site 2402)Southampton, Hampshire, United KingdomRecruiting
University College London Hospital-Clinical Research Facility ( Site 2405)London, London, City of, United KingdomRecruiting
The John Radcliffe Hospital ( Site 2406)Oxford, Oxfordshire, United KingdomRecruiting
Southmead Hospital ( Site 2403)Bristol, South Gloucestershire, United KingdomRecruiting
Walsall Manor Hospital ( Site 2410)West Midlands, Walsall, United KingdomActive, not recruiting
Study team and timeline
- Lead sponsor
- Merck Sharp & Dohme LLC
- Study start
- Jun 5, 2024 Actual
- Primary completion
- Oct 30, 2028 Estimated
- Study completion
- Nov 12, 2029 Estimated
- First posted
- May 28, 2024 Actual
- Last updated
- Nov 10, 2026 Actual
Official study contacts
Official study title
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Program to Evaluate the Efficacy and Safety of Tulisokibart in Participants With Moderately to Severely Active Crohn's Disease
Ask Wellness Clinical Research
Your message goes to WCR, including when this study is run by another organization. WCR may offer general guidance but may not operate this trial, have access to its team or be able to enroll you.
Source: ClinicalTrials.gov API v2. Information is submitted by sponsors and investigators. NLM does not approve the safety or science of all listed studies. Registry disclaimer.
Retrieved: Nov 11, 2026 · Last registry update: Nov 10, 2026
